SCHEMBL22471636

SCHEMBL22471636

CS(=O)(=O)c1nccc(I)n1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.37
▸ LMNA P02545 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ DYRK1A Q13627 1/20 0.32
▸ DYRK2 Q92630 1/20 0.32
▸ DYRK1B Q9Y463 1/20 0.32
▸ NPC1 O15118 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ XBP1 P17861 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ TLR9 Q9NR96 1/20 0.31
▸ BPTF Q12830 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27493492 0.79 KDM4E (0.32) LMNASMN1; SMN2ALDH1A1MAPTHTT
SCHEMBL1750195 0.77 PARP1 (0.38) PARP1LMNASMN1; SMN2DYRK1ADYRK2
SCHEMBL30637352 0.77 NPSR1 (0.42) PARP1LMNASMN1; SMN2NPC1ALDH1A1
SCHEMBL4138614 0.77 NPSR1 (0.42) PARP1LMNASMN1; SMN2NPC1ALDH1A1
SCHEMBL1490042 0.75 MTOR (0.37) PARP1LMNASMN1; SMN2DYRK1ADYRK2
SCHEMBL3929459 0.75 PARP1 (0.37) PARP1LMNASMN1; SMN2DYRK1ADYRK2
SCHEMBL20606050 0.75 LMNA (0.39) PARP1LMNASMN1; SMN2DYRK1ADYRK2
SCHEMBL13074743 0.75 PARP1 (0.37) PARP1LMNASMN1; SMN2DYRK1ADYRK2
SCHEMBL758549 0.75 TP53 (0.37) PARP1LMNASMN1; SMN2DYRK1ADYRK2
SCHEMBL28312314 0.75 PARP1 (0.37) PARP1LMNASMN1; SMN2DYRK1ADYRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724443-A1 PYRAZOLO-PYRIMIDINONE COMPOUNDS FOR USE IN METHODS OF INHIBITING WEE1 A KINASE Acrivon Therapeutics, Inc. (US) 2026-04-15 — — EP disclosed
WO-2024254490-A1 PYRAZOLO-PYRIMIDINONE COMPOUNDS FOR USE IN METHODS OF INHIBITING WEE1 A KINASE ACRIVON THERAPEUTICS, INC. (US) 2024-12-12 — — WO disclosed
CN-111356687-B Pyrimidine-containing tri-substituted imidazole compound and application thereof 广州必贝特医药技术有限公司 2021-03-30 — — CN disclosed
WO-2020192302-A1 PYRIMIDINE-CONTAINING TRI-SUBSTITUTED IMIDAZOLE COMPOUND AND APPLICATION THEREOF 广州必贝特医药技术有限公司 2020-10-01 — — WO disclosed
WO-2020192302-A1 PYRIMIDINE-CONTAINING TRI-SUBSTITUTED IMIDAZOLE COMPOUND AND APPLICATION THEREOF 广州必贝特医药技术有限公司 2020-10-01 — — WO disclosed
CN-111356687-A Pyrimidine-containing tri-substituted imidazole compound and application thereof 广州必贝特医药技术有限公司 2020-06-30 — — CN disclosed
CN-102395568-A Pyrimidine derivatives and their use as herbicides SYNGENTA LTD 2012-03-28 — — CN disclosed
Send feedback